Literature DB >> 829757

The value of cerebrospinal fluid immunoglobulin analysis in clincial neurology.

H Link.   

Abstract

The IgG index (formula: see text) corrects for the influence of serum protein abnormalities as well as a bloodbrain barrier damage and is, therefore, a better measure for the presence of an IgG elevation in CSF due to IgG synthesis, when compared with other IgG quotients commonly used. Agar gel electrophoresis of CSF for demonstration of oligoclonal IgG is probably superior to the determination of the IgG index when a diagnosis of MS is suspected. Determination of kappa and lambda light chain antigenic determinants in CSF, and calculation of the kappa/lambda ratio may also be used to demonstrate the occurrence of oligoclonal CSF immunoglobulins. An abnormal ratio can, however, be demonstrated only in 50% of MS patients and has, therefore, at present no place as a routine diagnostic method when MS is suspected.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 829757

Source DB:  PubMed          Journal:  Riv Patol Nerv Ment        ISSN: 0035-6433


  6 in total

1.  Isotachophoresis evaluation of synthesis of intrathecal IgG subfractions in multiple sclerosis.

Authors:  M Zaffaroni; D Caputo; C L Cazzullo
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

2.  Cerebrospinal fluid in multiple sclerosis.

Authors:  Kottil W Rammohan
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

3.  A case of benign recurrent meningitis of Mollaret.

Authors:  F Barontini; M Ghezzi; G P Marconi
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

4.  Demonstration of oligoclonal immunoglobulin G in Guillain-Barré syndrome and lymphocytic meningoradiculitis by isoelectric focusing.

Authors:  H Krüger; D Englert; K W Pflughaupt
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

5.  Sex-Related Differences in Cerebrospinal Fluid Plasma-Derived Proteins of Neurological Patients.

Authors:  Massimiliano Castellazzi; Caterina Ferri; Sarah Alfiero; Ilenia Lombardo; Michele Laudisi; Ginevra Tecilla; Michela Boni; Stefano Pizzicotti; Enrico Fainardi; Tiziana Bellini; Maura Pugliatti
Journal:  Diagnostics (Basel)       Date:  2021-05-16

6.  Immunological Subsets Characterization in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis.

Authors:  Emanuele D'Amico; Aurora Zanghì; Nunziatina Laura Parrinello; Alessandra Romano; Giuseppe Alberto Palumbo; Clara Grazia Chisari; Simona Toscano; Francesco Di Raimondo; Mario Zappia; Francesco Patti
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.